• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Emerging News and Research in Prostate Cancer Imaging — July 2024

News
Slideshow

Catch up on the most-well viewed prostate cancer imaging content in July 2024.

Touching on a variety of topics, ranging from locoregional staging and mpMRI-targeted biopsies to an emerging PSMA agent for metastatic castration-resistant prostate cancer (mCRPC), here are the top five most well-viewed prostate cancer imaging content for July 2024.

Recent Videos
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
Detecting PCa Recurrence in African Americans: Can 18F-Flotufolastat Have an Impact?
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Nina Kottler, MD, MS
Brian F. Chapin, MD
Related Content
© 2024 MJH Life Sciences

All rights reserved.